BSF Enterprise Plc (LSE: BSFA)
Health Care · Biotechnology · GB
£0.01
-2.22% today · -97.0% 1Y
BSF Enterprise Plc (LSE: BSFA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.86M and employs 14 people.
Over the last twelve months the share price has lost 97.0%, trading between 0.01 and 0.04.
Tweenvest scores BSF Enterprise Plc across four factors: quality 39/100, value 62/100. Its strongest factor is value.
BSFA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.86M
- Revenue (TTM)
- $67.43K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 3.63
- 52-week high
- £0.04
- 52-week low
- £0.01
- Avg volume (3M)
- —
- Shares outstanding
- 191.85M
- Employees
- 14
- Next earnings
- —
About BSF Enterprise Plc
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company develops and commercializes cell-based tissue engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. The principal activity of the Company is to undertake the acquisition of businesses in the biotechnology, marketing and e-commerce sectors.
- ISIN
- GB00BHNBDQ51
- Founded
- 2018
- Listed since
- Jul 26, 2019
- Exchange
- London Stock Exchange
- Currency
- GBP
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| VivoSim Labs, Inc.NasdaqCM: VIVS | $2.92M | $0.18 | -9.22% |
| GeoVax Labs, Inc.NasdaqCM: GOVX | $2.91M | $0.27 | -14.78% |
| Onconetix, Inc.NasdaqCM: ONCO | $2.90M | $0.64 | -13.32% |
| Quantum Genesis AI Corp.OTCPK: QGAI | $2.87M | $0.07 | -49.60% |
| Bioxytran, Inc.OTCPK: BIXT | $2.74M | $0.02 | +13.27% |
| BioRestorative Therapies, Inc.NasdaqCM: BRTX | $2.73M | $1.88 | -12.15% |
| Vaccinex, Inc.OTCPK: VCNX | $2.70M | $1.01 | +4.12% |
| Spermosens AB (publ)NGM: SPERM | $2.67M | Skr0.01 | -2.33% |
Figures last refreshed Oct 4, 2026.